Leaflet: information for the user
MST CONTINUS 15 mg prolonged-release tablets
Morphine sulfate
Read this leaflet carefully before you start taking the medicine because it contains important information for you.
1. What MST CONTINUS is and what it is used for
2. What you need to know before you start taking MST CONTINUS
3. How to take MST CONTINUS
4. Possible side effects
5. Storage of MST CONTINUS
6. Contents of the pack and additional information
These tablets have been prescribed by your doctor to relieve intense pain for a period of 12 hours. They contain the active substance morphine, which belongs to a group of powerful pain-relieving medications.
Tolerance, dependence, and addiction
This medicine contains morphine, which is an opioid. Repeated use of opioids can lead to a decrease in the effectiveness of the medicine (becoming accustomed to it, known as tolerance). Repeated use of this medicine can also lead to dependence, abuse, and addiction, which could lead to a potentially fatal overdose. The risk of these adverse effects may be higher with a higher dose and longer use.
Dependence or addiction can cause a lack of control over the amount of medicine you should use or the frequency with which you should use it.
The risk of dependence or addiction varies from person to person. You may have a higher risk of dependence or addiction to this medicine if:
If you notice any of the following symptoms while taking this medicine, it could be a sign of dependence or addiction:
If you notice any of these symptoms, consult your doctor to determine the best course of treatment for you, including when it is appropriate to discontinue the medicine and how to do it safely (see section 3 "If you interrupt treatment with MST CONTINUS").
If you are to undergo surgery, please tell your doctor that you are taking these tablets.
Warnings and precautions
Consult your doctor or pharmacist before starting to take this medicine.
Before starting treatment with these tablets, inform your doctor or pharmacist if you:
Generalized acute pustular exanthema (PEGA) associated with treatment with this medicine has been reported. Symptoms usually occur within the first 10 days of treatment. Inform your doctor if you have ever suffered a severe skin rash or skin peeling, blisters, or mouth sores after taking morphine or other opioids. Stop using this medicine and seek medical attention immediately if you notice any of the following symptoms: blisters, widespread skin peeling, or pus-filled points (pustules) along with fever.
Respiratory disorders related to sleep
This medicine may cause sleep-related respiratory disorders such as sleep apnea (pauses in breathing during sleep) and sleep-related hypoxemia (low oxygen levels in the blood), or worsen existing respiratory problems. Symptoms may include pauses in breathing during sleep, nocturnal awakening due to dyspnea, difficulty maintaining sleep, or excessive daytime somnolence. If you or someone else observes these symptoms, contact your doctor. Your doctor may consider reducing the dose.
Consult your doctor or pharmacist if you experience any of the following symptoms while taking this medicine:
Contact your doctor if you experience severe upper abdominal pain that may radiate to the back, nausea, vomiting, or fever, as it could be a sign of pancreatitis and bile duct inflammation.
This medicine should be used with caution when taking central nervous system depressants (see section "Taking MST CONTINUS with other medicines").
You may experience increased sensitivity to pain due to taking increasing doses of these tablets (hyperalgesia). Your doctor will decide if you need a change in dose or switch to another potent analgesic.
Use in athletes
This medicine contains morphine, which can produce a positive result in doping control tests.
Other medicines and morphine
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medicine.
It is particularly important to inform your doctor if you are taking:
Also inform your doctor if you have recently been treated with an anesthetic.
This medicine should not be administered simultaneously if you are taking a type of medicine to treat depression, called monoamine oxidase inhibitors (MAOIs) or within two weeks after stopping their use (see section 2 "Do not take...).
The concomitant use of morphine and sedatives such as benzodiazepines or related medicines increases the risk of somnolence, difficulty breathing (respiratory depression), coma, and may put your life at risk. Therefore, concomitant use should only be considered when other treatment options are not possible. However, if your doctor prescribes this medicine along with sedatives, your doctor should limit the dose and duration of concomitant treatment.
Inform your doctor of all sedatives you are taking and follow your doctor's recommended dose closely.
It may be helpful to inform friends or family members who are aware of the signs and symptoms indicated above. Contact your doctor when you experience these symptoms.
Taking this medicine with food and alcohol
Drinking alcohol while taking this medicine may make you feel more drowsy or increase the risk of severe adverse reactions such as shallow breathing with the risk of stopping breathing, and loss of consciousness. It is recommended not to drink alcohol while taking MST CONTINUS.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before using this medicine.
The tablets of this medicine should be avoided as much as possible in patients who are pregnant or breastfeeding.
If this medicine is used for a prolonged period during pregnancy, there is a risk that the newborn may experience withdrawal symptoms that should be treated by a doctor.
Driving and operating machines
These tablets may cause a range of side effects such as drowsiness, which could affect your ability to drive or operate machinery (see section 4 for a complete list of side effects). These effects are more noticeable when you start treatment with the tablets, or when your dose is increased. If you are affected, do not drive or operate machinery.
This medicine contains lactose:
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine.
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Before starting treatment and periodically during treatment, your doctor will explain what you can expect from the use of this medication, when and how long you need to take it, when to contact your doctor and when to interrupt it (see also the section “If you interrupt MST CONTINUS treatment”).
The tablets should be swallowed whole and not chewed with a glass of water.
Do not chew, crush or dissolve.
The tablets of this medication are designed to work properly for 12 hours when taken whole. If the tablet is broken, crushed, dissolved or chewed, the full 12-hour dose may be absorbed quickly by your body. This can be hazardous, causing severe problems such as an overdose, which can be fatal.
You should always take the tablets by mouth. The tablets should never be crushed or injected, as this can lead to severe adverse effects with a fatal outcome.
Do not increase the dose indicated by your doctor. If you do, you are at risk of taking an excessive amount of opioids (see section 4. Possible adverse effects).
There is a risk of tolerance (you need more doses to calm the pain) and addiction with strong opioid analgesics.
If you estimate that the action of this medication is too strong or too weak, inform your doctor or pharmacist.
You should take your tablets every 12 hours. Therefore, if you take a tablet at 8 am, you should take the next one at 8 pm.
Severe chronic pain:
Adults:
The usual initial dose is one 30 mg tablet every 12 hours.
This dose will depend on the intensity of your pain, your age and your previous history with analgesic therapy. Your doctor will decide how many tablets you should take.
Patients treated with other morphine oral preparations who switch to a treatment with morphine prolonged-release tablets should receive the same total daily dose of morphine, but divided into two doses (one in the morning and one at night).
Children:
In the case of severe and chronic pain, an initial dose of between 0.2 and 0.8 mg/kg every 12 hours is recommended.
Older adults (> 65 years): A dose reduction is advised.
Postoperative pain:
Adults: It is not recommended for use in the first 24 hours post-operatively; subsequently and always at the doctor's discretion, the following dosing schedule is suggested:
20 mg tablets every 12 hours in patients weighing less than 70 kg.
30 mg tablets every 12 hours in patients weighing more than 70 kg.
Children: This medication is not recommended for the treatment of postoperative pain in children.
Older adults (> 65 years):A dose reduction is advised
If you take more MST CONTINUS than you should
Inform your doctor immediately or go to the hospital. When you need medical attention, make sure to bring this leaflet with you and the tablets you have available to show to your doctor.
The signs of overdose and morphine toxicity are: small or pinpoint pupils, difficulty breathing, aspiration pneumonia and hypotension. In more severe cases, circulatory failure and eventually deep coma may occur.
People who have taken an overdose may suffer from aspiration pneumonia; symptoms may include shortness of breath, cough and fever.
People who have taken an overdose may also experience difficulty breathing that can cause loss of consciousness or even death.
If you have taken too many tablets, under no circumstances should you put yourself in a situation that requires you to be alert, for example, driving a car.
In case of overdose or accidental ingestion, consult the Toxicology Information Service, phone 915 620 420, indicating the medication and the amount ingested.
If you forgot to take MST CONTINUS
If you forgot to take a dose within 4 hours of the due time, take a tablet as soon as possible. Take your next tablet at your usual time. If the delay in taking is more than 4 hours, consult your doctor or pharmacist.
Do not take a double dose to compensate for the missed doses.
If you interrupt the treatment with MST CONTINUS
Do not stop treatment with this medication unless your doctor approves it. If you want to stop treatment with this medicationask your doctor how to gradually reduce the dose to avoid withdrawal symptoms. Withdrawal symptoms may include generalised pain, tremors, diarrhoea, stomach pain, nausea, flu-like symptoms, palpitations and dilated pupils. Psychological symptoms consist of a deep sense of dissatisfaction, anxiety and irritability.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine may cause side effects, although not everyone will experience them.
All medicines can cause allergic reactions, although severe allergic reactions are reported in rare cases. Inform your doctor immediately if you experience:
The most severe side effect, although rare, is when your breathing becomes slower or weaker than normal (respiratory depression, a typical risk of opioid overdose).
Like all strong painkillers, there is a risk of physical and psychological addiction or tolerance to these tablets.
Very common side effects
(May affect more than 1 in 10 patients)
Common side effects
(May affect up to 1 in 10 patients)
Uncommon side effects
(May affect up to 1 in 100 patients)
Unknown frequency
(Cannot be estimated from available data)
Reporting of side effects:
If you experience any type of side effect, consult your doctor or pharmacist, even if it is not listed in this leaflet. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use: www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the blister pack and carton, after CAD. The expiration date is the last day of the month indicated.
Keep the container perfectly closed to protect it from light and moisture. Store in the original packaging. Do not store at a temperature above 25°C.
Medications should not be disposed of through drains or trash. Dispose of containers and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of containers and medications you no longer need. By doing so, you will help protect the environment.
MST CONTINUS Composition
The active principle is morphine sulfate.
Each tablet contains 15 mg of morphine sulfate.
The other components are:
Appearance of MST CONTINUS and contents of the packaging
Coated tablets, biconvex, green in color, with a smooth face and the concentration “15” marked on the other face.
Carton packaging containing 60 tablets in PVC/PVCD-Al blisters.
Holder of the authorization
Mundipharma Pharmaceuticals, S.L.
Bahía de Pollensa,11
28042 Madrid
Spain
Phone: 913 821 870
Responsible for manufacturing
Mundipharma DC B.V.
Leusderend 16
3832 RC Leusden
Netherlands
Last review date of this prospectus:May 2024
The detailed information of this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es/)
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.